PR99980

HYDERABAD, India, April 20, 2023 /PRNewswire=KYODO JBN/ --

    - Fully equipped labs with 75-member team set-up and made operational in

<100 days

    Sai Life Sciences, one of India's fastest growing global Contract Research,

Development & Manufacturing Organisations (CRO-CDMO)

[https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=ssrl-inaugur

ation], today announced the opening of Sai Schrodinger Research Laboratories

(SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by

Dr. Karen Akinsanya, President of R&D, Therapeutics at Schrodinger Inc., in the

presence of members of the leadership team of Schrödinger and Sai Life Sciences.

    Inaugurating the facility, Dr. Karen Akinsanya said, "We selected Sai Life

Sciences as our CRO late last year, and we are extremely pleased that they are

now poised to begin work on our programs with a highly experienced and

dedicated team at a state-of-the-art facility. Sai Life Sciences will play an

important role in advancing our drug discovery and early development

activities, and we look forward to working closely together."

    In January 2023, Sai Life Sciences entered into a 5-year strategic

agreement with Schrodinger, whose physics-based computational platform is

transforming the way therapeutics and materials are discovered, to set up SSRL

in Hyderabad, India. Soon after, Sai Life Sciences commenced the build-up of

the facility along with recruitment of scientific staff, to drive the project

to completion in an accelerated time frame.

    Speaking at the occasion, Krishna Kanumuri, CEO & Managing Director, Sai

Life Sciences, said, "Our collaboration with Schrodinger marks an exciting new

start for us at Sai Life Sciences, with a dedicated facility to support

multiple discovery programs. The trust they've placed in us is a testimony to

the advances we have made in the scale, scope and depth of our integrated drug

discovery capabilities. I look forward to a productive collaboration."

    On the occasion, Dr. Karen Akinsanya and Krishna Kanumuri, met notable

officials representing the Hon'ble Minister for Industries & Commerce,

Government of Telangana, Shri KT Rama Rao, to apprise them of the nature of the

collaboration and the role that Sai Schrödinger Research Laboratories (SSRL)

will play in advancing drug discovery and development.

    Set up inside Sai Life Sciences' R&D campus in Genome Valley, SSRL is a

dedicated facility for integrated discovery

[https://www.sailife.com/services/discovery/integrated-drug-discovery-services/?

utm_source=pr&utm_medium=web&utm_campaign=ssrl-inauguration] work streams

including medicinal & synthetic chemistry

[https://www.sailife.com/services/discovery/synthetic-medicinal-chemistry/?utm_s

ource=pr&utm_medium=web&utm_campaign=ssrl-inauguration], in vitro biology

[https://www.sailife.com/services/discovery/biology/?utm_source=pr&utm_medium=we

b&utm_campaign=ssrl-inauguration], and process chemistry

[https://www.sailife.com/services/discovery/computational-chemistry-services/?ut

m_source=pr&utm_medium=web&utm_campaign=ssrl-inauguration]. SSRL will access

other Sai capabilities such as in vitro ADME

[https://www.sailife.com/services/discovery/dmpk-in-vitro-adme/?utm_source=pr&ut

m_medium=web&utm_campaign=ssrl-inauguration] and in vivo PK

[https://www.sailife.com/services/discovery/dmpk-in-vivo-pk/?utm_source=pr&utm_m

edium=web&utm_campaign=ssrl-inauguration] as needed. The relationship will

support advancement of programs that leverage Schrödinger's validated

computational platform. Currently, SSRL has 75 employees across

full-time-equivalents (FTEs) in Medicinal Chemistry, Biology, Process Chemistry

and Analytical Chemistry.

    About Sai Life Sciences

    Sai Life Sciences is a full-service CRO-CDMO that works with over 200

innovator pharma and biotech companies globally, to accelerate the discovery,

development, and commercialisation of complex small molecules. The company has

over 2600 employees across its facilities in India, UK and USA. Sai Life

Sciences is privately held and backed by global investors, TPG Capital and HBM

Healthcare Investments. https://www.sailife.com/

    Photo: https://mma.prnewswire.com/media/2059072/SSRL_Hyderabad_Campus.jpg

    Logo: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg

    Source: Sai Life Sciences